top of page

Petrina Kamya

VP & Global Head of AI Platforms at Insilico Medicine

Accomplished pharmaceutical R&D executive with strategic vision and over 35 years of demonstrated success in product discovery and early development, organizational leadership, and transformational R&D business models. Respected leader with the ability to identify and develop high-potential talent and influence thought leaders across organizational lines. Broad understanding of healthcare and the trends that are transforming the pharmaceutical and biopharmaceutical industries, and the need to create new partnering and financing approaches to ensure the future of the drug discovery and development ecosystem.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers

Laura Matz

Chief Science & Technology Officer at Merck Group

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jose Duca

Global Head of Computer-Aided Drug Discovery at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Nuno Prego Ramos

Founder & CEO of Valvian

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Werngard Czechtizky

Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Rudi Schmidt

Chief Operating Officer at Institute for Healthier Living Abu Dhabi

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Louis Boon

CSO of JJP Biologics

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Uli Schmidt

Executive Director, Structural Chemistry at Gilead Sciences

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS
bottom of page